1. Home
  2. Labeler Index
  3. Kobayashi Healthcare International, Inc.
  4. 52389-677
  5. NDC Package Code: 52389-677-42 Nauzene Chewables Ginger Honey

NDC Package 52389-677-42 Nauzene Chewables Ginger Honey

Sodium Citrate Tablet, Chewable Oral - View Billable Units, 11-Digit Format, RxNorm

Table of Contents

    1. Package Information
    2. Frequently Asked Questions

Package Information

Find all the important details about this NDC Package code, including the 11-Digit NDC Billing number, billing units, wholesale price, RxNorm crosswalk, active ingredients, pharmacologic clasess, etc.

NDC Package Code:
52389-677-42
Package Description:
3 BLISTER PACK in 1 CARTON / 14 TABLET, CHEWABLE in 1 BLISTER PACK
Product Code:
52389-677
Proprietary Name:
Nauzene Chewables Ginger Honey
Non-Proprietary Name:
Sodium Citrate
Substance Name:
Trisodium Citrate Dihydrate
Usage Information:
Adults: 2-4 tablets.Children: Consult a doctor for appropriate dosage.Chew tablets completely.Dosage may be repeated after 15 minutes, not to exceed 16 tablets in a 24-hour period unless advised by a doctor.Read all package directions and warnings before use and use only as directed.Nauzene Chewables are intended for use by normally healthy persons only.Persons under 18 years of age should use only as directed by a doctor.
11-Digit NDC Billing Format:
52389067742
NDC to RxNorm Crosswalk:
RxCUI: 2002800 - sodium citrate 230 MG Chewable Tablet
Product Type:
Human Otc Drug
Labeler Name:
Kobayashi Healthcare International, Inc.
Dosage Form:
Tablet, Chewable - A solid dosage form containing medicinal substances with or without suitable diluents that is intended to be chewed, producing a pleasant tasting residue in the oral cavity that is easily swallowed and does not leave a bitter or unpleasant after-taste.
Administration Route(s):
Oral - Administration to or by way of the mouth.
Active Ingredient(s):
TRISODIUM CITRATE DIHYDRATE 230 mg/1
Pharmacologic Class(es):
Sample Package:
No
FDA Application Number:
M001
Marketing Category:
OTC MONOGRAPH DRUG -
Start Marketing Date:
02-17-2025
Listing Expiration Date:
12-31-2026
Exclude Flag:
N
Code Structure:

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the disclaimer below.

Frequently Asked Questions

What is NDC 52389-677-42?

The NDC Packaged Code 52389-677-42 is assigned to a package of 3 blister pack in 1 carton / 14 tablet, chewable in 1 blister pack of Nauzene Chewables Ginger Honey, a human over the counter drug labeled by Kobayashi Healthcare International, Inc.. The product's dosage form is tablet, chewable and is administered via oral form.

Is NDC 52389-677 included in the NDC Directory?

Yes, Nauzene Chewables Ginger Honey with product code 52389-677 is active and included in the NDC Directory. The product was first marketed by Kobayashi Healthcare International, Inc. on February 17, 2025 and its listing in the NDC Directory is set to expire on December 31, 2026 if the product is not updated or renewed by the manufacturer.

What is the 11-digit format for NDC 52389-677-42?

The 11-digit format is 52389067742. The 11-digit billing format might be required by the Centers for Medicare & Medicaid Services (CMS) and other payers in billing claim forms.

This package code is originally configured in a 5-3-2 segment 10-digit format and by adding a zero within the original NDC package code we can obtain the converted 11-digit format in a 5-4-2 segment configuration. The table below shows the 11-digit code conversion:

10-Digit Format10-Digit Original Code11-Digit Format11-Digit Code
5-3-252389-677-425-4-252389-0677-42